Sandusky, OH, January 12, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today confirmed an update covering the company’s 2021 cannabis pharmaceutical and nutraceutical development outlook is scheduled this Thursday Jan 14th, 2021. In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC PINK: PURA) and RespRx from Kali-Extracts,
Sandusky, OH, January 5, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced a major step forward in the development of a CBD pharmaceutical product. PAOG today announced an engagement with Veristat, Inc., a contract research organization headquartered in Southborough Massachusetts. PAOG has engaged Veristat to assist in advancing
Tulsa, OK, November 17, 2020 – OTC PR WIRE — Renavotio, Inc (OTC US: RIII), (“Renavotio,” or the “Company”) today announced its recently-filed unaudited financial results for the third quarter ended September 30, 2020. For further information, please refer to the Company’s recently-filed 10Q on EDGAR. Revenue– Due to a new focus on domestic U.S.
Nutra Pharma is providing updates regarding debt restructuring and financing plans Plantation, Florida, November 4, 2020 — OTC PR WIRE — Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS),
Sandusky, OH, October 29, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced adding a nutraceutical development pathway to its existing pharmaceutical cannabis drug development strategy. Last week, PAOG announced a master services agreement with a clinical research organization (CRO) in the U.S. to prepare PAOG for initiating an investigational
Sandusky, OH – October 13, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today confirmed an agreement with Puration, Inc. (OTC PINK: PURA) to build a proprietary hemp cultivar development facility on PURA’s Farmersville, Texas branded site and announced an April 2021 target date for construction to be completed. PAOG recently
Sandusky, OH – October 1, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced engaging Saul Kaye the founder of iCAN (www.israel-cannabis.com) and CannaTech (www.canna-tech.co) to provide an independent review of PAOG’s RespRx research for the treatment of Chronic Obstructive Pulmonary Disease (COPD), and to help prepare RexpRx for engaging